Results 101 to 110 of about 395,984 (223)

Phototherapies mediated by metallic nanoparticles and near‐infrared radiation in skin cancer: A systematic review

Photochemistry and Photobiology, EarlyView.
Recent studies demonstrate that near‐infrared (NIR—750–980 nm)‐mediated photodynamic (PDT) and photothermal (PTT) therapies, combined with metallic nanoparticles (MNPs), show promising results against skin cancer, particularly melanoma, in both in vitro and in vivo models.
Tamyris Devincenzi, Alessandra Costa Lopes, Marcelo Augusto Germani Marinho, Daza de Moraes Vaz Batista Filgueira   +3 more
wiley   +1 more source

European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility [PDF]

, 2017
It is 30 yr since the British Journal of Anaesthesia published the first consensus protocol for the laboratory diagnosis of malignant hyperthermia susceptibility from the European Malignant Hyperthermia Group. This has subsequently been used in more than
Girard, T., Hardman, J. G., Pollock, N., Heytens, L., Silva, H., Rüffert, H., Street, N., Tegazzin, V., Krivosic-Horber, R., Urwyler, A., Islander, G., Sorrentino, V., Schuster, F., Hopkins, P. M., Snoeck, M. M., Tzanova, I., Glauber, V., Müller, C. R., Bandschapp, O., Glahn, K. P. E., Kraft, B., Gillies, R., Ellis, F. R., Klingler, W.   +23 more
core  

Cutaneous‐only hypersensitivity reaction presumed due to intravenous administration of atracurium in a dog

Veterinary Record Case Reports, Volume 14, Issue 4, November 2026.
Summary There are limited case reports of hypersensitivity reactions to neuromuscular blocking agents (NMBAs) in veterinary species, and none describe cutaneous‐only signs. This case report describes a Grade 1 cutaneous‐only hypersensitivity reaction to atracurium in a 7‐year‐old dog undergoing general anaesthesia for cataract surgery with bilateral ...
Kar Yee Phoon, Rob Ward
wiley   +1 more source

Malignant Hyperthermia and Nursing Knowledge

, 2017
Available to authenticated members of The University of Auckland.Background: Malignant hyperthermia is classed as a critical emergency. It is a situation where early recognition and initiation of treatment are essential for the safety of the patient, who
Marshall, Johanna
core  

Local Anaesthetic Dosing and Toxicity Knowledge in Australian Emergency Departments: A Multicentre Cross‐Sectional Survey

Emergency Medicine Australasia, Volume 38, Issue 5, October 2026.
ABSTRACT Objectives Local anaesthetic systemic toxicity (LAST) is a rare but potentially fatal complication of local anaesthetic (LA) use. This study assessed knowledge of LA dosing, LAST recognition and management among emergency clinicians in Australia.
Andrew Follows, Ben Rose, Andrew Ross, Abby McCaughey   +3 more
wiley   +1 more source

Malignant Hyperthermia [PDF]

Physical Therapy, 2001
J K, Kozack, D L, MacIntyre
openaire   +2 more sources

Malignant Hyperthermia - the Hidden Danger

, 2017
Introduction: Malignant hyperthermia (MH) is a life-threatening elevation in body temperature usually resulting from a hypermetabolic response to concurrent use of a muscle relaxant and an inhalational general anesthetic.
Angelov, Plamen, Dinkov, Anton, Mitsova, Dimana, Stefanova, Aleksandra, Stoyanova, Elena   +4 more
core   +1 more source

Response to equine cardiac adverse events during sports

Equine Veterinary Education, Volume 38, Issue 10, Page 556-564, October 2026.
Summary Cardiac adverse events and sudden death are a feared scenario for equine veterinarians, with serious consequences for animal health, riders' safety and the social licence to operate equestrian sports. The response to equine cardiac adverse events (CAEs) during sports is poorly defined.
C. Navas de Solis, J. Keen, A. Decloedt, B. Delvescovo, K. Hopster, K. Mitchell, J. Slack, G. van Loon, G. Van Steenkiste, L. Nath   +9 more
wiley   +1 more source

Malignant Hyperthermia: A Clinical Crisis [PDF]

, 2015
Malignant hyperthermia, though uncommon, is a serious and life threatening condition. Malignant hyperthermia is an autosomal dominant disorder that affects skeletal muscle.
Reing, Eric
core  

Nanomaterial Strategies for Pulmonary Delivery of Immunotherapeutics in Lung Cancer Treatment

Advanced Healthcare Materials, Volume 15, Issue 34, 11 September 2026.
Inhalable immunotherapeutic nanomedicines enable organ‐selective immune modulation by overcoming pulmonary delivery barriers and concentrating therapy within lung tumors. This Review defines how nanomaterial properties govern airway deposition, retention, cellular partitioning, and immune activation across vaccines, checkpoint blockade, STING agonists,
Han Zhang, Wei Tang
wiley   +1 more source